Journal
CELL METABOLISM
Volume 18, Issue 6, Pages 831-843Publisher
CELL PRESS
DOI: 10.1016/j.cmet.2013.11.002
Keywords
-
Categories
Funding
- Human Frontiers Science Program (HFSP)
- National Institute for Translational Neuroscience (INNT/Brazil)
- Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)
- Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)
- Canadian Institutes for Health Research (CIHR)
- Canada Research Chair Program
- CNPq predoctoral fellowships
Ask authors/readers for more resources
Alzheimer's disease (AD) and type 2 diabetes appear to share similar pathogenic mechanisms. dsRNA-dependent protein kinase (PKR) underlies peripheral insulin resistance in metabolic disorders. PKR phosphorylates eukaryotic translation initiation factor 2 alpha (eIF2 alpha-P), and AD brains exhibit elevated phospho-PKR and eIF2 alpha-P levels. Whether and how PKR and eIF2 alpha-P participate in defective brain insulin signaling and cognitive impairment in AD are unknown. We report that beta-amyloid oligomers, AD-associated toxins, activate PKR in a tumor necrosis factor alpha (TNF-alpha)dependent manner, resulting in eIF2 alpha-P, neuronal insulin receptor substrate (IRS-1) inhibition, synapse loss, and memory impairment. Brain phospho-PKR and eIF2 alpha-P were elevated in AD animal models, including monkeys given intracerebroventricular oligomer infusions. Oligomers failed to trigger eIF2 alpha-P and cognitive impairment in PKR-/- and TNFR1(-/-) mice. Bolstering insulin signaling rescued phospho-PKR and eIF2 alpha-P. Results reveal pathogenic mechanisms shared by AD and diabetes and establish that proinflammatory signaling mediates oligomer-induced IRS-1 inhibition and PKR-dependent synapse and memory loss.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available